Back to CELG-RI
Douglas Lane & Associates, LLC → CELG-RI
Douglas Lane & Associates, LLC CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
5
Latest value
$93.8M
Q3 2026
Peak value
$95.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $69.4M |
| Q4 2025 | $84.8M |
| Q1 2026 | $95.5M |
| Q2 2026 | $89.7M |
| Q3 2026 | $93.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $93.8M | 1.50M | — | — |
| Q2 2026 | $89.7M | 1.56M | — | — |
| Q1 2026 | $95.5M | 1.57M | — | — |
| Q4 2025 | $84.8M | 1.57M | — | — |
| Q3 2025 | $69.4M | 1.54M | — | — |
Other funds holding CELG-RI
$11.1B
$9.6B
$8.5B
$7.9B
$5.9B
$5.9B
$5.8B